Screener
Ionis Pharmaceuticals IONS Ionis Operations — Medical Affairs Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:MedicalAffairsExpenses.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Cost of sales | 2,563 | 3,541 | 5,398 | 4,904 |
| Drug discovery | 29,120 | 30,255 | 57,677 | 57,244 |
| Drug development | 103,958 | 117,689 | 208,140 | 230,635 |
| Medical affairs | 11,318 | 7,826 | 21,307 | 13,468 |
| Manufacturing and development chemistry | 20,639 | 21,545 | 40,947 | 35,826 |
| R&D support | 26,974 | 20,607 | 49,405 | 41,159 |
| Selling, general and administrative | 130,075 | 81,081 | 262,012 | 148,061 |
| Other segment items (1) | 57,948 | 45,954 | 76,330 | 75,750 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's ionis operations — medical affairs expenses?
- Ionis Pharmaceuticals (IONS) reported ionis operations — medical affairs expenses of $11.32M in Q2 2026.
- How has Ionis Pharmaceuticals's ionis operations — medical affairs expenses changed year-over-year?
- Ionis Pharmaceuticals's ionis operations — medical affairs expenses increased by 44.6% year-over-year, from $7.83M to $11.32M.
- What is the long-term trend for Ionis Pharmaceuticals's ionis operations — medical affairs expenses?
- Over 3 years (2022 to 2025), Ionis Pharmaceuticals's ionis operations — medical affairs expenses has grown at a 26.1% compound annual growth rate (CAGR), from $15.95M to $32.01M.
- What does ionis operations — medical affairs expenses mean?
- These expenses relate to the activities of the medical affairs team, including medical education, scientific exchange with healthcare professionals, and support for clinical data dissemination. It reflects the company's effort to build scientific credibility and support the clinical utility of its products.
Ask your AI about Ionis Pharmaceuticals's ionis operations — medical affairs expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude